Egerton Capital UK LLP Trims Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Egerton Capital UK LLP trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 19.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,572,382 shares of the company's stock after selling 1,107,639 shares during the quarter. GE HealthCare Technologies makes up about 4.1% of Egerton Capital UK LLP's portfolio, making the stock its 11th biggest position. Egerton Capital UK LLP owned 1.00% of GE HealthCare Technologies worth $357,469,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. D1 Capital Partners L.P. purchased a new position in GE HealthCare Technologies during the 3rd quarter worth $268,159,000. Van ECK Associates Corp increased its holdings in GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after purchasing an additional 2,506,417 shares during the period. State Street Corp increased its holdings in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after purchasing an additional 1,347,114 shares during the period. Massachusetts Financial Services Co. MA purchased a new position in GE HealthCare Technologies during the 3rd quarter worth $93,713,000. Finally, Jennison Associates LLC increased its holdings in GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company's stock worth $133,659,000 after purchasing an additional 948,017 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the company. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their target price for the company from $85.00 to $100.00 in a research report on Tuesday. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.75.

Remove Ads

GE HealthCare Technologies Stock Up 0.3 %

GE HealthCare Technologies stock opened at $85.59 on Wednesday. The stock has a market capitalization of $39.14 billion, a price-to-earnings ratio of 19.77, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The business has a fifty day moving average price of $87.06 and a 200-day moving average price of $86.17. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.